These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39295704)

  • 41. [Neonatal systemic pseudohypoaldosteronism type I].
    Cao XC; Chen YY; Zhang K; Zhang XJ; Yang L; Li ZH
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):774-778. PubMed ID: 37529962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia.
    Attia NA; Marzouk YI
    Case Rep Endocrinol; 2016; 2016():6384697. PubMed ID: 26904317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pseudohypoaldosteronism types I and II: little more than a name in common.
    Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
    J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient pseudohypoaldosteronism masquerading as congenital adrenal hyperplasia.
    Manikam L; Cornes MP; Kalra D; Ford C; Gama R
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):380-2. PubMed ID: 21525149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
    Riepe FG; Holterhus PM
    Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pseudohypoaldosteronism associated with hypertrophic cardiomyopathy, hypertension and thrombocytosis due to mutation in the ELAC2 gene: a case report.
    Mendes LC; de Oliveira Magalhães R; Pereira Dos Santos RK; Araújo RS
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1437-1442. PubMed ID: 35946480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular and skin manifestations in systemic pseudohypoaldosteronism.
    Eliwa MS; El-Emmawie AH; Saeed MA
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24654255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac arrest in a newborn: A case of pseudohypoaldosteronism.
    Tauber KA; Ermacor K; Listman J
    Clin Case Rep; 2024 Feb; 12(2):e8265. PubMed ID: 38344358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.
    Kanda K; Nozu K; Yokoyama N; Morioka I; Miwa A; Hashimura Y; Kaito H; Iijima K; Matsuo M
    BMC Nephrol; 2009 Nov; 10():37. PubMed ID: 19912655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pseudohypoaldosteronism type 1 in an infant with bilateral primary obstructive megaureter : a case report].
    Makino Y; Kanematsu A; Imamura M; Yoshimura K; Nishiyama H; Yorifuji T; Ogawa O
    Hinyokika Kiyo; 2011 Apr; 57(4):193-7. PubMed ID: 21646850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pseudohypoaldosteronism in infants with salt wasting syndrome. Two case reports].
    Szalecki M; Wójcik E; Domagała Z; Małunowicz E
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):33-6. PubMed ID: 17493404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Management in Systemic Type Pseudohypoaldosteronism Due to
    Karacan Küçükali G; Çetinkaya S; Tunç G; Oğuz MM; Çelik N; Akkaş KY; Şenel S; Güleray Lafcı N; Savaş Erdeve Ş
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):446-451. PubMed ID: 32840096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudohypoaldosteronism type 1: management issues.
    Sharma R; Pandey M; Kanwal SK; Zennaro MC
    Indian Pediatr; 2013 Mar; 50(3):331-3. PubMed ID: 23680607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hook effect: a pitfall leading to misdiagnosis of hypoaldosteronism in an infant with pseudohypoaldosteronism.
    Akin L; Kurtoglu S; Kendirci M; Akin MA; Hartmann MF; Wudy SA
    Horm Res Paediatr; 2010; 74(1):72-5. PubMed ID: 20431271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudohypoaldosteronism type 1: clinical features and management in infancy.
    Amin N; Alvi NS; Barth JH; Field HP; Finlay E; Tyerman K; Frazer S; Savill G; Wright NP; Makaya T; Mushtaq T
    Endocrinol Diabetes Metab Case Rep; 2013; 2013():130010. PubMed ID: 24616761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Pseudohypoaldosteronism Type 1 Due to a Novel Mutation in SCNN1B Gene: A Case Report.
    Joshi K; Verma PK; Barman M
    EJIFCC; 2022 Oct; 33(3):268-273. PubMed ID: 36447799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
    Tropschuh A; de Potzolli B; Seeliger S
    Klin Padiatr; 2020 Jan; 232(1):29-32. PubMed ID: 31914462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism.
    Nozu K; Fu XJ; Kaito H; Kanda K; Yokoyama N; Przybyslaw Krol R; Nakajima T; Kajiyama M; Iijima K; Matsuo M
    Pediatr Nephrol; 2007 Aug; 22(8):1219-23. PubMed ID: 17401586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.